Preliminary data from the first three dose levels demonstrates encouraging anti- tumor activity with CF33-hNIS monotherapy, including one patient with cholangiocarcinoma, treated intratumorally, who ...

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient ...

An oncolytic virus called CF33 developed at City of Hope shows potential for colon cancer treatment and tumor regrowth immunity in mouse models. In preclinical research done on mouse models, the ...

Encouraging early results from the VAXINIA (CF33) oncolytic virus trial, including one complete response in a patient with cholangiocarcinoma (bile tract cancer) and two partial responses in patients ...

A cancer-killing virus that scientists developed could one day improve the immune system's ability to eradicate tumors in colon cancer patients, reports a new study. The preclinical research is a ...

DUARTE, Calif.--(BUSINESS WIRE)--A cancer-killing virus that City of Hope scientists developed could one day improve the immune system’s ability to eradicate tumors in colon cancer patients, reports a ...

The Windows 10 2-in-1 market is full of options fitting just about every possible user need, from tablets that convert to notebooks, notebooks that convert to tablets, convertibles with 360-degree ...

Most high-end notebooks or 2-in-1s are robust only to an extent and are not meant for rugged use. Panasonic’s Toughbook and Dell’s Latitude Rugged are better equipped in this regard and can survive a ...

Panasonic Toughbook CF-33 is a wonderful device for those who work in demanding conditions. Over the past few years, all the ‘oohs’ and ‘aahs’ about laptops have been over how thin, light or fast they ...

SYDNEY, AUSTRALIA / ACCESSWIRE / January 18, 2024 / Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, is pleased to announce further details from its poster presentation at the ASCO ...